Passage of Zika virus in -deficient mice selects for unique envelope glycosylation motif mutants that show enhanced replication
Eri Nakayama,Bing Tang,Romal Stewart,Abigail L. Cox,Kexin Yan,Cameron R. Bishop,Troy Dumenil,Wilson Nguyen,Andrii Slonchak,Julian Sng,Alexander A. Khromykh,Viviana P. Lutzky,Daniel J. Rawle,Andreas Suhrbier
DOI: https://doi.org/10.1101/2024.09.06.611742
2024-09-06
Abstract:N-linked glycosylation of flavivirus envelope proteins is widely viewed as a requirement for optimal folding, processing and/or transit of envelope proteins, and the assembling virons, through the endoplasmic reticulum (ER) and Golgi. Herein we show that serial passage of ZIKV in mice generated two unique envelope glycan-deficient mutants, ZIKV-V153D and ZIKV-N154D, that, surprisingly, produced titers ∼1 to 2.6 logs than the glycosylated parental ZIKV in Vero E6 cells and human brain organoids. RNA-Seq of infected organoids suggested that this increased replication fitness was associated with upregulation of the unfolded protein response (UPR). Cell death, cellular viral RNA and viral protein levels were not significantly affected, arguing that these glycan mutants enjoyed faster ER/Golgi folding, processing, assembly, transit, and virion egress, assisted by an upregulated UPR. Thus, ZIKV envelope N-linked glycosylation is not essential for promoting envelope folding, assembly and transit through the ER/Golgi, as aspartic acid (D) substitutions in the glycosylation motif achieve this with significantly greater efficiency. V153D and N154D mutants have not been employed in flavivirus envelope glycosylation studies. Instead, mutants such as N154A have been used, which may impart unfavorable properties that have a greater impact than the loss of the glycan. ZIKV-V153D and -N154D may avoid this by preserving the surface negative charge provided by the glycan moiety in the parental ZIKV . In mice ZIKV-V153D and -N154D showed faster viremia onsets, but reduced viremic periods, than the parental ZIKV , consistent with the contention that these glycans have evolved to delay neutralizing antibody activity.
Microbiology